glutathione mutations in sclc patients vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Oncology Reports

Oncology Reports NRF2 supports non small cell lung cancer growth independently of CBP p300 enhanced glutathione synthesis EMBO Reports Springer Nature Link Glutathione Dependent Pathways in Cancer Cells Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Small cells big issues: biological implications and preclinical advancements in small cell lung cancer Molecular Cancer Springer Nature Link Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology

SKU: 37428536560 · From southroadsurgery.com.au